Puriblood Medical Past Earnings Performance
Past criteria checks 0/6
Puriblood Medical's earnings have been declining at an average annual rate of -23.6%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 22.8% per year.
Key information
-23.6%
Earnings growth rate
-10.2%
EPS growth rate
| Medical Equipment Industry Growth | 11.5% |
| Revenue growth rate | 22.8% |
| Return on equity | -27.1% |
| Net Margin | -36.1% |
| Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Puriblood Medical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 127 | -46 | 31 | 27 |
| 31 Mar 24 | 126 | -49 | 31 | 26 |
| 31 Dec 23 | 125 | -52 | 31 | 26 |
| 30 Sep 23 | 97 | -29 | 31 | 25 |
| 30 Jun 23 | 68 | -7 | 31 | 25 |
| 31 Mar 23 | 103 | 5 | 30 | 24 |
| 31 Dec 22 | 137 | 17 | 29 | 22 |
| 30 Sep 22 | 139 | -2 | 28 | 22 |
| 30 Jun 22 | 141 | -21 | 28 | 22 |
| 31 Mar 22 | 98 | -29 | 24 | 21 |
| 31 Dec 21 | 55 | -38 | 20 | 21 |
| 30 Sep 21 | 46 | -26 | 18 | 19 |
| 30 Jun 21 | 37 | -15 | 16 | 17 |
| 31 Mar 21 | 38 | -9 | 15 | 16 |
| 31 Dec 20 | 39 | -3 | 13 | 15 |
| 31 Dec 19 | 3 | -21 | 8 | 13 |
Quality Earnings: 6847 is currently unprofitable.
Growing Profit Margin: 6847 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6847 is unprofitable, and losses have increased over the past 5 years at a rate of 23.6% per year.
Accelerating Growth: Unable to compare 6847's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6847 is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (1.7%).
Return on Equity
High ROE: 6847 has a negative Return on Equity (-27.11%), as it is currently unprofitable.